Is there a role for immunotherapy in HER2-positive breast cancer?

Saved in:
Bibliographic Details
Title: Is there a role for immunotherapy in HER2-positive breast cancer?
Authors: Holgado E; 1Ramon y Cajal University Hospital, Ctra, Colmenar Viejo km. 9,100, 28034 Madrid, Spain.; IOB Institute of Oncology, Quiron Group, Madrid, Spain., Perez-Garcia J; 3IOB Institute of Oncology, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain.; 4Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Gion M; 1Ramon y Cajal University Hospital, Ctra, Colmenar Viejo km. 9,100, 28034 Madrid, Spain., Cortes J; 1Ramon y Cajal University Hospital, Ctra, Colmenar Viejo km. 9,100, 28034 Madrid, Spain.; IOB Institute of Oncology, Quiron Group, Madrid, Spain.; 5Vall d´Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain.
Source: NPJ breast cancer [NPJ Breast Cancer] 2018 Aug 15; Vol. 4, pp. 21. Date of Electronic Publication: 2018 Aug 15 (Print Publication: 2018).
Publication Type: Journal Article; Review
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2374-4677
DOI:10.1038/s41523-018-0072-8